Exclusion criteria were (1) diagnosed sleep disorder other than RLS; (2) a major mental illness; (3) a significant history of cognitive difficulties; and (4) prior (within one year) or current use of a neuroleptic agent.
After receiving a detailed explanation of the protocol, all subjects provided their informed consent to the study.
Questionnaire, Interview, and Data Collection
In agreement with the rules suggested by the National Institutes of Health in collaboration with members of the International Restless Legs Syndrome Study Group, 1, 16 all patients and controls underwent a face-to-face interview using a structured questionnaire. The questionnaire covered the following aspects: demographics, medical and drug history, sleep habits, sleep disorders, and a detailed description of RLS symptoms when present. Interviews were conducted by a sleep medicine expert (board certified by the Italian Association of Sleep Medicine or by the French Sleep Research Society) at each center.
Subjects were considered to have RLS if they met the 4 standard diagnostic criteria: 1 (1) leg restlessness, usually accompanied or caused by uncomfortable and unpleasant sensations in the legs; (2) beginning or worsening of this unpleasant sensation during rest or inactivity such as lying or sitting; (3) partial or total relief of the unpleasant sensations by movement, and (4) worsening or occurrence of the unpleasant sensations in the evening or night compared to daytime. In addition, the frequency of occurrence of RLS symptoms was at least twice per week during the 6 months preceding the interview. Patients and controls with RLS underwent the validated self-administered International RLS Rating Scale 25 (10 items, score range between 0 and 40) to measure the severity of their RLS symptoms. A retrospective review of the medical reports assessed whether patients and controls had undergone blood tests during the 2 months preceding the interview, in which case serum iron and ferritin were collected, if available.
Statistical Analysis
Differences between NC patients and controls for age and anthropometric measures were tested by Student t-test; the χ 2 test was used for sex composition. The statistical analysis included descriptive statistics and comparisons between patients and controls or between patients with or without RLS; the χ 2 test and Student t-test were used, as appropriate. The odds ratio (and 95% confidence interval) for the prevalence of RLS in NC subjects and normal controls were also computed. Moreover, binomial logistic regression was used to determine the best predictors for the presence or absence of RLS in NC. Binomial logistic regression is a form of regression used when the dependent variable is dichotomous and the independent variables are continuous or nominal. We first conducted a series of individual logistic regression analyses with RLS status used as a dependent variable and each parameter considered in this study as the predictor. After this step, we included the predictors which yielded a statistically significant result in additional logistic regression analyses using different combinations of these significant predictors. To rule out the possibility that the difference found in ferritin levels in the 2 NC subgroups was due to their different ages, we also performed a linear regression analysis between these parameters. Finally, to confirm the results of these analyses, we performed a discriminant analysis which is a powerful approach to determine which variables discriminate between two or more naturally occurring groups, such as our NC subjects with or without RLS. The most common application of this analysis is to include several measures in the study to determine those that discriminate between groups. We performed the socalled stepwise discriminant analysis which builds a model of discrimination step by step. At each step all variables are reviewed, and the one which will contribute most to discrimination between groups is selected and included in the model. The stepwise procedure is based on the F value for a variable which indicates its statistical significance in the discrimination between groups. Table 1 lists the demographic and the anthropometric characteristics of all the subjects enrolled in the study. The 2 groups of subjects (NC patients and controls) did not differ regarding the age, whereas a small disproportion was present for sex composition with relatively fewer males in the control group (126 males and 109 females, M/F 1.16) compared to NC patients (119 males and 65 females, M/F 1.83; χ 2 test 5.20, P = 0.0226). Weight and, consequently, body mass index were significantly higher in the patient group than in controls. Table 2 shows the comparison between the prevalence of RLS in NC patients and in control subjects. NC patients showed a significantly higher prevalence of RLS (14.7%) than normal controls (3.0%); the odds ratio was 5.6, with the lower 95% confidence interval of 2.38.
RESULTS

Comparison between NC Patients and Normal Controls
Characteristics of RLS in NC Patients
As shown in Table 2 , we found 27 NC patients with RLS (RLS+); 21 were males and 6 were females with a male/female ratio of 3.5. A similar sex ratio was reported in NC patients without RLS (RLS−), i.e. 1.7. Mean age at onset of RLS in NC patients was 32.1 years (SD 14.9) and the average score at the IRLSSG rating scale 25 was 18.8 (SD 8.5). These values were not significantly different from those found in controls, who had a mean age at onset of RLS of 30.3 years (SD 19.4) and an average score at the IRLSSG rating scale of 13.5 (SD 4.9). 35 .0% of them also reported diurnal symptoms of RLS. Interestingly, 12.5% of them were taking specific drug therapy for RLS at the time of their visit to the sleep laboratory but none had taken this type of treatment before they contacted a sleep center.
Search for Predictive Factors of RLS in NC Patients
The search for predictive factors of RLS in NC patients was based on logistic regression models which included several items collected and used as predictors. In our case, the logistic regression models indicate to what extent each single criterion can predict patients with or without RLS. From the statistics calculated for the logistic regression analysis, we used the adjusted coefficient of determination (adjusted R 2 ) as a measure of variability explained by the predictors. The adjusted R 2 is computed as 1 minus the ratio of the mean square residual over the mean square total and adjusts for number of predictors in the model. Adjusted R 2 is particularly useful in the feature selection stage of model building. A P-value < 0.05 was considered to indicate a significant prediction of each item for the diagnosis of RLS. We first performed a number of independent logistic regression analyses, one for each item collected. Categorical items were entered into the logistic regression analysis with their categories ''1 = present" and ''0 = not present." Table 3 lists the individual logistic regression analyses of different features in NC patients with or without RLS. Only 3 items reached statistical significance and, thus, seem to have a predictive value for the presence of RLS: age (older in RLS+ NC patients), level of blood ferritin (higher in RLS+ NC patients), and presence of sleep paralysis (higher in RLS+ NC patients).
Subsequently, we entered these predictive features in different combinations in the logistic regression analysis in an attempt to build a more complex predictive model (Table 4) . With this approach, we found that the highest significant adjusted R 2 values were obtained by the combination "Age + Ferritin." Nonsignificant regressions were probably due to the low number of subjects with all information available.
To further investigate the possibility that the differences found in ferritin levels in the two NC subgroups were due to their different ages, we performed a linear regression analysis which ruled out such a correlation (r = 0.120, NS). Finally, we attempted to confirm further the results of the logistic regression analysis by means of another approach designed to determine which variables discriminate between our 2 groups, i.e., NC subjects with or without RLS. For this purpose, we performed a stepwise forward discriminant analysis with RLS status used as the grouping variable and age, sex, sleep paralysis, and ferritin used as independent factors. The final model comprised 3 predictive factors (F 3,83 = 2.953; P < 0.0373): sleep paralysis, ferritin, and age. This model yielded a probability of 0.184 for RLS+ status and of 0.816 for RLS status, with 83.9% of correct classifications in our sample. The coefficients provided by the model can be combined in the following predictive formula for new cases: 
DISCUSSION
Our study offers the first significant evidence that RLS is more prevalent among the NC population than age-matched controls.
Although the most disabling feature is excessive sleepiness, patients with NC frequently also report disturbed nocturnal sleep. 26 In particular, PLMs are reported to occur much more frequently in NC patients than in the general population. 7, 23 PLMs are also strongly associated with RLS 27 ; however, leg motor activity periodicity was reported to be lower in patients with NC than in those with idiopathic RLS. 28 To date, no studies have investigated the comorbidity of NC and RLS, except for a single case report of a NC patient who developed RLS after taking sodium oxybate, 17 and an anecdotal report of two patients with RLS out of nine narcoleptic patients in a large cohort of patients with neurological diseases. 7 Our results now show that RLS is significantly more prevalent among the NC population (14.7%) than in normal controls (3.0%), resulting in an odds ratio of 5.6. The prevalence found in our control group confirms literature data on the prevalence of clinically significant RLS in the general population, with symptoms occurring at least 2 times per week. 12 Our NC patients and controls were well matched for age, but less for sex, as the group of patients included more males, in agreement with previous reports. 29, 30 However, it is well known that RLS is more common in women; thus if any differences in this study were based on sex alone, one would expect to find a lower prevalence of RLS in narcolepsy rather than the higher prevalence we found. The age of NC patients with RLS in our study confirmed literature data on age at onset in idiopathic RLS 30 and was significantly higher than that of NC patients without RLS. Age at onset of RLS is known to vary widely from childhood to more than 80 years with differences regarding primary vs. secondary RLS cases. 8 Age at onset of RLS in our NC patients was around 32 years (approximately 10 years after NC onset). Familial occurrence was reported in only 15.4% of cases, in contrast with idiopathic RLS subjects, 50% of whom had a positive family history 16 ; 42% of our controls subjects had a family history of RLS. day; diurnal symptoms were also present in 35% of cases. The latter finding may be due to excessive sleepiness that affects the daytime functioning of NC patients, which might lead to a poor circadian distribution of RLS symptoms in NC. As a consequence, we may speculate that the treatment of excessive daytime sleepiness potentially improves RLS in NC. The nature of the association between NC and RLS could be ascribed to a common pathophysiologic mechanisms shared by the two disorders and already suggested to explain the occurrence of significant PLMS in NC. 23, 28 There is evidence for the crucial role of dopaminergic impairment in the pathophysiology of RLS, 20, 31 confirmed by the efficacy of dopaminergic drugs on RLS symptoms. 32 Similarly, modifications in dopaminergic pathways were also reported in NC with lowered metabolism of dopamine, 21 genetic differences (through catechol-O-methyltransferase gene), 33 and altered striatal postsynaptic D2 receptors SPECT findings. 22 Being a critical downstream mediator of hypocretin deficiency, all these data implicate the dopamine system in the pathophysiology of motor symptoms in NC. 23, 24, 34 Logistic regression models disclosed only three items that seemed to have a predictive value for RLS in NC patients, i.e., age (older in RLS+ NC patients), blood ferritin levels (higher in RLS+ NC patients), and sleep paralysis (more common in RLS+ NC patients).
Older age as a predictive factor for the occurrence of RLS in NC patients confirms literature data on the increased prevalence of RLS among the elderly, especially in cases of secondary or comorbid RLS. 29, 30 On the contrary, the role of the higher ferritin levels is difficult to explain but could be ascribed to the hypothesized autoimmune mechanism of NC. 35 Hence, they might also be an expression of iron storage modification typical of inflammatory diseases and some neurodegenerative diseases. 36 Moreover, ferritin is increased in obesity, 37 and NC patients usually have a higher than normal BMI, as also confirmed in our study. However, it is difficult to explain the increased ferritin values in the group of NC patients with RLS, since iron deficiency is thought to be a predisposing factor for the emergence of idiopathic RLS. 38 We may hypothesize that different pathophysiological mechanisms exist in secondary RLS, particularly in RLS associated with NC. Since NC patients with RLS were older than those without and since serum ferritin increases with age, 39 we performed a linear regression analysis to test this hypothesis. It appears unlikely that the differences obtained between the two subgroups depended only on Lastly, IRLS score in NC patients with RLS did not significantly differ from that of controls with RLS and showed a moderate severity of the disease with symptoms almost every age. Thus, our data suggest that iron storage could play a role in the association between NC and RLS, as this was a consistent and reproducible finding in all three centers participating in the study; however, the way it promoted RLS remains unknown. Lastly, ferritin serum levels may not reflect the iron brain level, especially in secondary RLS in the context of NC. The predictive role of sleep paralysis for the occurrence of RLS in NC patients is intriguing, and it can suggest some speculations. Sleep paralysis is considered to be a manifestation of the normal atonia (muscle paralysis) of REM sleep, occurring at an inopportune moment, while the patient is at rest, mostly in the wake-sleep and sleep-wake transition. Patients find themselves unable to move for a few minutes. This sensation of powerlessness, occurring while the patient is falling asleep, could trigger the RLS symptoms. Alternatively, RLS could induce a condition of partial sleep deprivation, enhancing SP. However, we cannot exclude that these symptoms also share some common mechanism, being clonazepam efficacious in treating both SP 40 and RLS. 38 Acknowledging that RLS has been reported as a side effect of second generation antidepressant, 18 we carefully searched for a possible iatrogenic effect. In our sample, however, we could not find any significant difference in prevalence of RLS between patients who took or did or did not take SSRIs (none of the patients was using tricyclic antidepressants).
Despite some limits to this study, such as the lack of information on PLMS and ferritin data for some patients, the strong association between NC and RLS remains the main statistically significant finding. RLS must be addressed in evaluating the nocturnal sleep impairment 26 of NC patients in whom the co-occurrence of RLS may impair sleep quality, increase sleep latency at night, and, above all, worsen excessive daytime sleepiness.
The significant association of NC and RLS may finally represent an important finding for the management of NC. The RLS response to a dopamine-agonist agent in NC also needs to be assessed. Additional studies are necessary to confirm our findings and to clarify possible common pathophysiological mechanisms underlying NC and RLS.
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